Five Liters, the blood health & hemostasis division of Spark Biomedical, Inc., the developer of transcutaneous auricular neurostimulation (tAN®). tAN, currently FDA-cleared for opioid withdrawal treatment, is the first non-invasive neuromodulation treatment in clinical trials to improve patients’ lives related bleeding disorders, surgical blood loss and other blood-related health condition.